Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Synoste
107
Synoste
Health Care
Medical
Medical Devices
Synoste develops next-generation medical solutions for the treatment and correction of skeletal deformities. Its implants for lengthening limbs are based on a mechanism using smart metals that operate safely and painlessly for the patient.
Suggest edits
Founded
2012
Raised
$8.1M
Follow us
Companies in the same industry
Lunaphore
Accel Diagnostics
D-EYE
WOLK Company
Branchpoint Technologies
Sana
TopGene
Trice Medical
Saluda Medical
Earlens Corporation
Alexa global traffic share
Overview
Funding
3
Add info
Add round
18 Oct
2018
€5,100,000
Venture capital
Lifeline Ventures
,
AO Invest
Medical Device Company Synoste Raises €5.1M
FinSMEs
21 Jan
2016
Venture capital
Evonik Venture Capital
Venture Capital: Evonik invests in SYNOSTE, a medical technology start-up in Düsseldorf and Helsinki Industries - Specialty Chemicals
evonik
06 May
2015
$2,200,000
Venture capital (Series A)
Finnvera Venture Capital
,
High-Tech Gruenderfonds
,
Lifeline Ventures
,
+3
Synoste Oy raises € 2.2 M in the first closing of A-round financing to acquire CE-approval for a next generation implant for correcting skeletal deformities
High-Tech Gründerfonds
